VALPROIC ACID INDUCES DIFFERENTIATION OF A SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR
- 1 January 2004
- journal article
- review article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 21 (8) , 743-751
Abstract
In preclinical models the antiepileptic drug valproic acid induces differentiation of neoplastic cells, representing an evolving anticancer approach that takes into account that malignant cells resemble immature progenitor cells capable of terminal differentiation. The authors report on a child suffering from a relapsing supratentorial primitive neuroectodermal tumor that received valproic acid for epilepsy treatment over 7 months before the relapse. In contrast to the initial tumor, the relapsing tumor showed glial differentiation and low proliferation index. This is the first report of a relapsed supratentorial primitive neuroectodermal tumor that shows histologically confirmed signs of tumor cell differentiation induction.Keywords
This publication has 25 references indexed in Scilit:
- Increase of Fetal Hemoglobin Synthesis Indicating Differentiation Induction in Children Receiving Valproic AcidPediatric Hematology and Oncology, 2003
- Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour‐associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhoodNeuropathology and Applied Neurobiology, 2002
- Valproate and Valproate-Analogues: Potent Tools to Fight Against CancerCurrent Medicinal Chemistry, 2002
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002
- Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER updateMedical and Pediatric Oncology, 2002
- Population-based epidemiologic data on brain tumors in German childrenCancer, 2001
- Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in miceJournal of Clinical Investigation, 2000
- Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factorsChild's Nervous System, 1999
- Valproic acid for the treatment of pediatric malignant gliomaKlinische Padiatrie, 1999
- Molecular Characterization of Glioblastoma Cell DifferentiationNeurosurgery, 1997